Mindy Marie Sampson, DO
Infectious Disease · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sampson’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$26,584
Medicare paid this office $26,584 for 75 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $10,036 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $6,286 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,320 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,145 | $121 |
Who their Medicare patients are
75 Original Medicare patients in 2024. Average age 72 · Under 65 20% · 85 and older 16% · Women 48% · Also on Medicaid 49% · Health risk score 2.95. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Chronic kidney disease 63% · Heart failure 53% · Atrial fibrillation 44% · Diabetes 43% · Coronary heart disease 41% · Depression 33% · Cancer 31% · Dementia 29% · COPD 27% · Stroke 23%.
The office billed $115,176, Medicare allowed $33,079 and paid $26,584; for 246 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 75 | 246 | 72 | 2.95 | $115,176 | $26,584 |
| 2023 | 49 | 3,553 | 68 | 3.07 | $48,783 | $10,776 |
| 2022 | 101 | 3,786 | 68 | 3.03 | $66,648 | $15,012 |
| 2021 | 180 | 10,363 | 68 | 2.53 | $231,042 | $49,810 |
| 2020 | 275 | 29,112 | 70 | 2.86 | $288,141 | $61,769 |
| 2019 | 103 | 29,018 | 65 | 3.01 | $149,681 | $33,486 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $3,359 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,755 | $103 |
| Return visit (30+ min) | 11 | $592 | $54 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $6,052 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 34 | $3,515 | $103 |
| Return visit (30+ min) | 14 | $1,705 | $85 |
2021: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $7,555 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 61 | $6,655 | $107 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 29 | $6,430 | $55 |
| Return visit (30+ min) | 23 | $3,106 | $86 |
| Injection, ertapenem sodium, 500 mg | 11 | $2,957 | None |
| Short return visit (20+ min) | 22 | $2,146 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,030 | $79 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $717 | $36 |
2020: 9 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 120 | $14,054 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $13,526 | $62 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | $7,803 | $52 |
| New patient visit (45+ min) | 24 | $2,825 | $118 |
| Return visit (30+ min) | 29 | $2,368 | $72 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 44 | $1,942 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,574 | $87 |
| Short return visit (20+ min) | 20 | $1,100 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $762 | $30 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $9,123 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,473 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,441 | $80 |
| Return visit (30+ min) | 16 | $1,130 | $71 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $848 | $30 |
| Short return visit (20+ min) | 15 | $846 | $53 |
Medicaid work
$1,255 in 2024
Medicaid paid $1,255 for 20 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $1,255 |
| 2024 | 20 | 1 | 12 | $1,255 |
| 2021 | 69 | 1 | 13 | $2,917 |
| 2020 | 75 | 1 | 17 | $3,190 |
| 2019 | 82 | 1 | 16 | $2,690 |
See the largest Medicaid services in earlier years
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 69 | $2,917 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 75 | $3,190 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 82 | $2,690 |
Money from drug and device companies
$77 in 2020
| 2020 | 1 | 2 | None | $77 |
| 2019 | 4 | 8 | None | $258 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Insmed | Arikayce | $77 | 2 payments
|
See all 2 published payments
| Insmed | Education · 2020-11-30 | None | $16 |
| Insmed | Meals · 2020-03-06 | Arikayce | $61 |
See earlier years (2019)
2019: $258
| Insmed | Arikayce | $99 | 1 payment
|
| Gilead Sciences | None | $84 | 4 payments
|
| Melinta Therapeutics | Vabomere | $56 | 2 payments
|
| Astellas Pharma US | Cresemba | $19 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Regeneron Pharmaceuticals, Inc. · A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike Sars-Cov-2 Monoclonal Antibodies in Preventing Sars-Cov-2 Infection in Household Contacts of Individuals Infected With Sars-Cov-2 · 2021 | Their institution | $77,711 |
| Regeneron Pharmaceuticals, Inc. · A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike Sars-Cov-2 Monoclonal Antibodies in Preventing Sars-Cov-2 Infection in Household Contacts of Individuals Infected With Sars-Cov-2 · 2020 | Their institution | $23,885 |
| Regeneron Pharmaceuticals, Inc. · A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike Sars-Cov-2 Monoclonal Antibodies in Preventing Sars-Cov-2 Infection in Household Contacts of Individuals Infected With Sars-Cov-2 · 2022 | Their institution | $18,439 |
| Regeneron Pharmaceuticals, Inc. · A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike Sars-Cov-2 Monoclonal Antibodies in Preventing Sars-Cov-2 Infection in Household Contacts of Individuals Infected With Sars-Cov-2 · 2023 | Their institution | $2,661 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 95.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1528486057
- Licence
- CA 20A21594
- Trained
- Edward Via Col of Osteo Medicine-Carolinas Campus, 2014
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2014-04-02
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 10660 Park Rd, Charlotte, NC, 28210 · 1225 Harding Pl, Charlotte, NC, 28204 · 1350 S Kings Dr, Charlotte, NC, 28207 · 200 Medical Park Dr, Concord, NC, 28025
This office lists an electronic records connection.